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A public health risk assessment for yellow fever vaccination: a model
exemplified by an outbreak in the state of São Paulo, Brazil
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We propose a method to analyse the 2009 outbreak in the region of Botucatu in the state of São Paulo (SP), Brazil,
when 28 yellow fever (YF) cases were confirmed, including 11 deaths. At the time of the outbreak, the Secretary of
Health of the State of São Paulo vaccinated one million people, causing the death of five individuals, an unprecedented number of YF vaccine-induced fatalities. We apply a mathematical model described previously to optimise
the proportion of people who should be vaccinated to minimise the total number of deaths. The model was used to
calculate the optimum proportion that should be vaccinated in the remaining, vaccine-free regions of SP, considering the risk of vaccine-induced fatalities and the risk of YF outbreaks in these regions.
Key words: yellow fever - vaccination - side-effects - mathematical models - optimisation - risk estimation

Yellow fever (YF) is an haemorrhagic fever caused
by the prototype member of the genus Flavivirus (a name
which translates from Latin as “yellow virus”) family Flaviridae (Monath 2001, Moreno et al. 2011). This family
comprises approximately 70 viruses (Moreno et al. 2011),
most of which are transmitted by arthropod insects (hence
the name arthropod born viruses or arboviruses). Genomic
sequence analysis suggests that the YF virus evolved from
other mosquito-borne viruses 3,000 years ago (Zanotto et
al. 1996). It is an infection endemic in the tropical forests
of Africa and Central and South America (Barnett 2004).
In these regions, YF is enzootic and it is maintained by
circulating in non-human primates and is transmitted by
diurnally active mosquitoes (Haemagogus spp and Sabethes spp in the Americas and Aedes spp in Africa). During occupational or recreational activities in forest areas,
susceptible individuals are bitten by mosquitoes carrying
the YF virus and develop the clinical disease with varying degrees of severity. These individuals may eventually
return infected to their home cities, which is of particular
concern in urban regions infested by Aedes aegypti (YF
vector of the urban cycle of the disease), the same transmitter of dengue fever and the mosquito responsible for
huge YF outbreaks in urban centres in the past.
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With 738 cases and 478 deaths, the last outbreak of
urban YF in Brazil happened in Rio de Janeiro in 19281929 and in 1942, Brazil was declared free of YF by the
Pan American Health Organization (Monath 1991). In
1958, the 20 year national campaign for the eradication
of Ae. aegypti was successful and the mosquito disappeared from Brazilian cities. In 1967, the mosquito reinfested the states of Pará and Maranhão, but this reinfestation was short-lived and the mosquito was again
eradicated in 1973. Unfortunately, in 1976 Ae. aegypti
invaded Brazil again through the port of Salvador, state
of Bahia, and spread throughout the country, infesting
more than 80% of the Brazilian cities since then. Urban
YF has never resurged and the diseased remained enzootic, causing occasional sporadic human cases (Costa et
al. 2011, Moreno & Barata 2011).
Recently, however, YF re-emerged in the Central
and Southeast Regions of Brazil, causing 51 cases and
21 deaths from 2008-2009 (Fortaleza et al. 2009). As a
consequence, public health authorities intensified the YF
vaccination programme. In the state of São Paulo (SP),
approximately eight million doses of YF vaccine were administered between 1999-2008. This amount corresponds
to approximately 19% of the entire state population (cve.
saude.sp.gov.br/cgi/deftohtm.exe?cvetab/pnisp/pnidos.def).
In this paper, we propose a method to analyse the
2009 outbreak in the region of Botucatu, SP, when 28 YF
cases were confirmed, including 11 deaths (Mascheretti
et al. 2013). At the time of the outbreak, the Secretary
of Health of the State of São Paulo vaccinated one million people, causing the death of five individuals, an
unprecedented number of YF vaccine-induced fatalities. We apply a mathematical model described previously to optimise the proportion of people who should
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TABLE I
Parameters used in the simulations of modela
Parameter

Biological meaning

Value
0.78 day-1
1.0

gh

Mosquitoes’ biting rate
Probability of transmission from infected
mosquitoesto susceptible humans
Inverse of the intrinsic incubation period in humans

mh

Natural mortality rate of humans

3.91 x 10 -5 day-1

ah
nh
mv
c

Yellow fever (YF)-induced mortality rate in humans
YF vaccination rate
Vaccine-induced mortality rate
Probability of transmission from infected
humans to susceptible mosquitoes
Natural mortality rate of mosquitoes
YF-induced mortality rate in mosquitoes
Extrinsic incubation period in mosquitoes
Proportion of preemptive vaccination

0.1 day-1
10 -5 day-1
2.1 x 10 -10 day-1
1.0

a
b

mM
aM
t
p

0.14 day-1

0.15 day-1
0
7 days
Variable

a: The dynamical system (Supplementary data).

be vaccinated to minimise the total number of deaths
(Massad et al. 2005). The model was used to calculate
the optimum proportion that should be vaccinated in the
remaining, vaccine-free regions of SP, considering the
risk of vaccine-induced fatalities and the risk of YF outbreak in these regions. This work should be viewed as a
methodological proposal rather than a definitive public
health intervention policy.
MATERIALS AND METHODS

If p is the proportion of the population that is preemptively vaccinated in campaigns before outbreaks, we
can express the expected total number of deaths or serious
adverse events, D(p), due to vaccination and potential YF
outbreaks as (Bauch et al. 2003, Massad et al. 2005):
D(p) = Nh {pdv + r(1- p)[pyf (p)dyf + pv(p)d*v (p)]}
where Nh is the size of the human population, dv is the
probability of developing serious adverse events (including deaths) after being pre-emptively vaccinated, r is the
risk of an outbreak, dyf is the probability of dying of YF, pyf
(p) is the probability of getting the infection if not vaccinated, pv(p) is the probability of receiving the vaccine during the outbreak and d*v (p) is the probability of developing
serious adverse events (including death) from the vaccine
received during the outbreak. The quantity dv , the risk of
vaccine-induced fatality rate, was assumed to be equal to
5.0 x 10-6 doses-1, which was the value observed in 2009 in
the region of Botucatu (Mascheretti et al. 2013). The risk
of outbreak (r) is described below. The quantities dyf (p), pyf
(p), pv(p) and d*v (p) were calculated through a dynamic
system described in The dynamical system, Supplementary data. Therefore, we are considering the possibility of
vaccination before and during an eventual outbreak.

The term Nh pdv in equation is the number of serious adverse events (including deaths) of those individuals pre-emptively vaccinated in campaigns before outbreaks. The second term in equation, Nhr(1- p)[(dyf (p) - d*v
(p))pyf (p) + pv(p)d*v (p)] is the number of serious adverse
events (including deaths) after an outbreak, due to death
by YF infection and of serious adverse events (including
deaths) due to vaccination during the outbreak.
We then minimise D(p) on the unit interval (0 ≤ p ≤
1) to determine the group optimum, pgr,which is the coverage level that would have to be imposed to minimise
the total expected number of serious adverse events
(including deaths).
The results of the equation simulation (Table I) are
presented in Figs 1-3, considering the risk of vaccineinduced fatality rate of 5.0 x 10 -6 dose-1 observed in 2009
in the region of Botucatu (Mascheretti et al. 2013) for
various estimated risks of outbreaks (see below).
We then applied the Delphi method to estimate
the potential risk of outbreaks in several regions of SP
(Dalkey & Helmer 1963, Massad et al. 1999, Ortega et
al. 2003). The method was originally developed as a systematic, interactive forecasting method which relies on
a panel of experts. The experts answer questionnaires in
two or more rounds. After each round, a facilitator provides an anonymous summary of the experts’ forecasts
from the previous round as well as the reasons they provide for their judgments. Therefore, experts are encouraged to revise their earlier answers based on the replies
of other members of their panel. During this process, the
range of the answers will decrease and the group will
converge towards the “correct” answer. Finally, the process is stopped after a pre-defined stop criterion (e.g.,
number of rounds, achievement of consensus and stabil-
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Fig. 1: simulation of model (The dynamical system, Supplementary
data) showing that the parameters chosen reproduce, in the equilibrium, the observed risk of vaccine-induced death after the Botucatu
outbreak. The time scale is not relevant because the intent is just to
demonstrate that the vaccination rate applied determined a lethality at
equilibrium compatible with the one observed.

Fig. 2: simulation of model (The dynamical system, Supplementary
data) showing that the parameters chosen reproduce, in the equilibrium, the observed number of YF cases and deaths during the
Botucatu outbreak.

TABLE II
Variables and values attributed by the Secretary of Health of the State of São Paulo staff through the Delphi method
Variables
Region

A

B

C

D

E

F

G

H

I

J

K

L

Total

Capital
Santo André

1
1

1
1

2
1

1
1

0
0

1
1

1
1

2
2

2
2

0
0

0
0

-2
-1

9
9

Mogi das Cruzes

1

1

2

1

0

1

1

2

2

0

0

-1

10

Franco da Rocha

1

1

2

1

0

1

1

2

2

0

0

0

11

Osasco

1

2

2

1

0

1

1

1

2

0

0

-1

10

Botucatu

2

2

2

2

2

2

2

2

2

2

2

0

22

Campinas

2

1

2

2

1

1

1

2

1

1

0

0

14

Piracicaba

2

2

1

2

2

2

1

1

0

2

0

0

15

Registro

2

1

2

1

1

2

1

2

2

2

2

0

18

Santos

2

2

2

2

0

2

1

2

2

0

0

-1

14

São João da Boa Vista

2

1

1

1

2

1

1

2

1

2

1

0

15

São José dos Campos

2

1

2

1

1

0

0

1

1

0

0

0

9

Taubaté

1

1

2

1

1

0

0

2

2

1

1

0

12

Sorocaba
Caraguatatuba

2
2

2
2

2
2

1
2

2
0

1
2

1
1

2
2

1
2

2
0

2
0

0
0

18
15

A: presence of sylvatic vectors; B: presence of Aedes aegypti; C: presence of non-human primates; D: cases of dengue; E: river
basins; F: climatic conditions; G: landscape; H: vegetation; I: fragmentation; J: proximity to the area of vaccine recommendation;
K: rural population; L: urbanization density.

ity of results) and the mean or median scores of the final
rounds determine the results.
During four meetings, the professionals of epidemiological surveillance, laboratory, vector control and
the environment of the Centre of Epidemiological Surveillance, Adolpho Lutz Institute, Superintendence of

Endemics Control and São Paulo Secretariat of the Environment discussed the risk of introduction of YF in
new regions. We evaluated and assigned a score to define the risk in the epidemiological surveillance groups
without recommendation of vaccination. The following
variables were scored as 0, +1 or +2: presence of sylvatic
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less than 100%. Therefore, it is the minimum risk that has
100% of coverage as the optimum level. According to Fig.
3B, we see that for 0% of vaccination, the total mortality in Botucatu (uppermost line) is approximately 11 (the
actual observed value) and for 100% it was five (also the
actual observed number of deaths due to the vaccine). All
the other risks attributed to the regions were calculated as
a linear proportion of the reference risk assigned to Botucatu. The results are shown in Supplementary Table I.
Fig. 4 shows the map of SP with the proposed optimal
vaccination strategies for the unaffected areas. The calculated optimum proportion for vaccination against YF according to model (The dynamical system, Supplementary
data) is shown in Supplementary Table II and Fig. 3A, B.
DISCUSSION

Fig. 3: results of the simulation of D(p) / Nh from equation (main text),
representing the per capita probability of death either by the disease or the
vaccine. A: the three-dimensional figure showing D(p) / Nh as a function
of proportion of preemptive vaccination, p, and the risk of outbreak, r; B:
a profile of A, with only the risk of outbreaks, as in Supplementary Table
II. The red triangles correspond to the minimum values of each curve.

vector, presence of Ae. aegypti, presence of non-human
primates, dengue cases, river basin, climatic conditions,
landscape, vegetation, fragmentation, proximity to the
area of vaccine recommendation and rural population.
The urbanisation density, the number of buildings per
area of each region, was represented by the scores 0, -1
or -2. The eventual presence of non-explained deaths of
non-human primates in any of the regions was not included in the risk analysis because, according to the current vaccination policy, if the non-human primate corpse
is negative for the YF virus, then the risk is considered
zero. If, in contrast, it is positive for YF, then the risk is
considered 100% and the vaccination recommendation
strategy is triggered. The results are shown in Table II.
Based on the Delphi scores, it was possible to estimate the relative risks of outbreaks for each region using
the case of Botucatu as a reference. The risk assigned to
Botucatu was equal to 40% or 0.4. This value was chosen because it is the minimum risk that resulted in 100%
optimum vaccination coverage. In other words, the value
of the risk assigned to Botucatu was such that no other
risk value greater than that results in optimum coverage

Since its reintroduction in Brazilian regions in 1976,
Ae. aegypti spread throughout the country, infesting
more than 80% of urban centres (Costa et al. 2011).
The current circulation of YF virus in SP was associated with the high mobility of susceptible humans
to enzootic YF areas. The virus eventually returned as
viraemia to the Ae. aegypti infested home cities, which
represents an enormous risk for urban YF re-emergence.
Vaccination, therefore, is the main tool available to prevent the catastrophe represented by the re-emergence of
urban YF. Even if we consider an unprecedented high
rate of serious vaccine-induced adverse effects similar
to the one observed in the Botucatu outbreak, vaccinating a high proportion of susceptible people in still unaffected areas should be indicated.
Presently, the surveillance policy against YF by the
Brazilian Ministry of Health consists of maintaining
high vaccination coverage of the so-called “recommendation” areas (dark green in Fig. 4) and triggering a mass
vaccination action intended to cover entire areas where
virus circulation is detected either in humans or non-human primates. This type of indiscriminate vaccination
policy is far from optimum and therefore, an analysis
such as the one proposed in this paper could help optimise the vaccination coverage necessary in each area.
Our results were based on the high level of vaccine-induced mortalities never observed before. If we consider the
more accepted levels of vaccine-induced mortality proportions such as 2.5 deaths per one million doses as in Massad
et al. (2005), the optimum vaccination doses required for
minimising the total probability of death would be even
higher than the levels we are proposing for the still unaffected areas. It is important to emphasise, however, that the
aim of this paper was to propose a methodology to estimate
the optimum vaccination strategies that would minimise
the death both by the disease and by the vaccine.
In addition to the vaccine-induced mortality frequency, another critical parameter considered by our model
is the expected risk of outbreak. We applied a relatively
simple method for estimating those risks, but a more sophisticated analysis of the outbreak risk for each unaffected area would refine our results. Moreover, our model
assumes various oversimplifications of the dynamics of
YF such as the absence of an age component in transmission and several other sources of heterogeneities. The
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Fig. 4: map of the state of São Paulo with the proposed optimal vaccination strategies for the unaffected areas. “Recommended”
means indiscriminate vaccination of 100% of the area.

quality of the data used, collection system and its accuracy of association between vaccination and related deaths
are weaknesses of our estimations. Our work, therefore,
should be viewed as a methodological proposal rather
than a definitive public health intervention policy.
If a vaccination strategy such as the one proposed in
this paper is actually implemented in the regions where
the optimum vaccination proportion is less than 100%,
then the fraction of the population that should be vaccinated would be calculated by fractioning the risk regionally within the area.
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